Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Februar 2020

Planlagt Fastgjort Låst Flyttet Genmab
1.7k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • P Offline
    P Offline
    Peter_Panik
    wrote on sidst redigeret af
    #799

    Bullish: Jeg styrer alt selv.

    1 Reply Last reply
    0
    • M Offline
      M Offline
      Mcjean
      wrote on sidst redigeret af
      #800

      Det statement ville jeg så tage med et gran salt med det efternavn:-D

      1 Reply Last reply
      0
      • B Offline
        B Offline
        bibob
        wrote on sidst redigeret af
        #801

        😄

        1 Reply Last reply
        0
        • J Offline
          J Offline
          JKY_VH
          wrote on sidst redigeret af
          #802

          haha

          1 Reply Last reply
          0
          • Helge_LarsenPI-redaktørH Offline
            Helge_LarsenPI-redaktørH Offline
            Helge_LarsenPI-redaktør
            wrote on sidst redigeret af
            #803

            😄

            1 Reply Last reply
            0
            • R Offline
              R Offline
              Rune2494
              wrote on sidst redigeret af
              #804

              Når jeg som "fattig" universitetsstuderende spytter lidt i hatten, så håber jeg også nogle af jer tunge drenge hoster op med en sjat småpenge til sultanen ham selv. Tak for masser af aktivitet herinde de forgangene dage - MEGET værdsat af en amatør som jeg selv 🙂

              1 Reply Last reply
              0
              • BulderB Offline
                BulderB Offline
                Bulder
                wrote on sidst redigeret af
                #805

                Det kører: De fører parallelle forhandlinger med flere partnerkandidater på epcoritamab. Et antal af disse har allerede accepteret, at Genmab får US-market. Mid this year or sooner!

                1 Reply Last reply
                0
                • B Offline
                  B Offline
                  bibob
                  wrote on sidst redigeret af
                  #806

                  Forhandlings taktik eller hva. ?? . Jeg tror det bliver J&J da de sikkert ikke vil lade deres guldkalv smutte med deres pæne pipeline. 😉

                  1 Reply Last reply
                  0
                  • J Offline
                    J Offline
                    JKY_VH
                    wrote on sidst redigeret af
                    #807

                    Tænker det samme bibob. Bruges guidens i virkeligheden som en presser i forhandlingerne? Vil I med og have en del af kagen eller skal vi køre selv og tage det hele? The winner takes it all, som Abba sang.

                    1 Reply Last reply
                    0
                    • O Offline
                      O Offline
                      OHW
                      wrote on sidst redigeret af
                      #808

                      Fra Børsen:at jeg altid har holdt fast i mine aktier. Vi er kun ved begyndelsen, og jeg mener, at 2020 kan blive et vendepunkt for selskabet, hvor det kan komme ind i en fase, hvor det kan fordobles eller tredobles i værdi," siger Jan van de Winkel.

                      1 Reply Last reply
                      0
                      • BulderB Offline
                        BulderB Offline
                        Bulder
                        wrote on sidst redigeret af
                        #809

                        Winkel antyder, at Janssen overvejer at droppe dara i solide og i stedet satse på hex-cd38.

                        1 Reply Last reply
                        0
                        • B Offline
                          B Offline
                          Bullish
                          wrote on sidst redigeret af
                          #810

                          Nu kom Nordea: Fastholder Hold, hæver fair value til 1,339 per share (1,315)

                          1 Reply Last reply
                          0
                          • Legolas23L Offline
                            Legolas23L Offline
                            Legolas23
                            wrote on sidst redigeret af
                            #811

                            Hvad med hexa kombi med dara?

                            1 Reply Last reply
                            0
                            • B Offline
                              B Offline
                              Bullish
                              wrote on sidst redigeret af
                              #812

                              Ja så er det nok nemmere at have mit navn, @Peter Panik - emnet er flyttet til aktiesnakken.

                              1 Reply Last reply
                              0
                              • E Offline
                                E Offline
                                E_L
                                wrote on sidst redigeret af
                                #813

                                Bryan Garnier

                                GENMAB BUY | DKK1900 vs. DKK1700 Higher-than.expected 2020 OPEX guidance could be good entry point
                                2020 guidance has caught the consensus off the guard
                                Earlier lines will drive Darzalex’s growth in the coming years
                                Epcoritamab and GEN1046 represent the next generation
                                FV increased to DKK 1,900 and Buy rating reiterated

                                1 Reply Last reply
                                0
                                • BulderB Offline
                                  BulderB Offline
                                  Bulder
                                  wrote on sidst redigeret af
                                  #814

                                  Hvis det i forvejen er et cd38-bindende molekyle, som de vil bruge til at danne hexamerer med, ved jeg ikke om det giver mening at kombinere med dara. Det kan Sukker måske sige noget om?

                                  1 Reply Last reply
                                  0
                                  • E Offline
                                    E Offline
                                    E_L
                                    wrote on sidst redigeret af
                                    #815

                                    My understanding was that it would be a replacement for Dara? New and improved...

                                    1 Reply Last reply
                                    0
                                    • StockBullS Offline
                                      StockBullS Offline
                                      StockBull
                                      wrote on sidst redigeret af
                                      #816

                                      Ser godt ud. Tror dog stadig på retracement i kommende uge. Vi har lige banked imod toppen af den opadgående trendkanal fra Oktober 2018 https://nbg1.your-objectstorage.com/proinvestor-dev/forum/boards/81884_genmab_1734.JPG

                                      1 Reply Last reply
                                      0
                                      • BulderB Offline
                                        BulderB Offline
                                        Bulder
                                        wrote on sidst redigeret af
                                        #817

                                        Then, the use of daratumumab after a PD-1 or PDL-1 checkpoint blockers in solid tumors that's entirely up to Janssen. Janssen is following the field. They are looking at the Sanofi work with isatuximab and they have already said publicly that they are willing to move into solid tumors again with daratumumab, but then they will use SubQ daratumumab. And don't forget that we know of also this new HexaBody CD38 program, which will go into the clinic this year, which Genmab will drive, Asthika.

                                        1 Reply Last reply
                                        0
                                        • BulderB Offline
                                          BulderB Offline
                                          Bulder
                                          wrote on sidst redigeret af
                                          #818

                                          That molecule is so much more potent than daratumumab pre-clinically that we think that also that molecule has the potential to move into trials in solid cancers.

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger